Recent developments in the investigation of inherited metabolic disorders using cultured human cells

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 243-257

  Roe, Charles R ^a   Roe, Diane S ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acylcarnitines; Amino acids; Fat oxidation; Fibroblasts; Mitochondrial disorders; Peroxisomal disorders; Tandem mass spectrometry

Indexed keywords

ACYLCARNITINE; BRANCHED CHAIN AMINO ACID; CARNITINE; FATTY ACID; ISOLEUCINE; LEUCINE; LIPID; PALMITIC ACID; VALINE;

AMINO ACID METABOLISM; AMNION CELL; CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INBORN ERROR OF METABOLISM; ISOTOPE LABELING; LIPID OXIDATION; MAJOR CLINICAL STUDY; MITOCHONDRION; PEROXISOME; PRIORITY JOURNAL; SHORT SURVEY; TANDEM MASS SPECTROMETRY;

EID: 0032732526     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2911     Document Type: Article

References (41)

1. Millington D S, Kodo N, Terada N, Roe D S, Chace D H. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom Ion Processes. 111:1991;211-228.
2. Rashed M S, Ozand P T, Bucknall M P, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitine and amino acid profiling using automated electrospray tandem mass spectrometry. Pediatr Res. 38:1995;324-331.
3. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
4. Kolvraa S, Gregersen N, Christensen E, Hobolth N. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-coA dehydrogenase. Clin Chim Acta. 126:1982;53-67.
5. Saudubray J M, Coude F X, Demaugre F, Johnson C, Gibson K M, Nyhan W L. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res. 16:1982;877-881.
6. 14C-Labeled substrate catabolism by human diploid fibroblasts derived from infants and adults. Biochem Med. 34:1985;182-188.
7. Rhead W J. Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview. Tanaka K Coates PM. Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. 1990;365-382 A. R. Liss, New York.
8. Wanders R JA, Denis S, Ruiter J PN, Schutgens R BH, vanRoermund C WT, Jacobs B S. Measurement of peroxisomal fatty acid β-oxidation in cultured human skin fibroblasts. J Inher Metab Dis. 18:1995;113-124.
9. VanVeldhoven P P, Huang S, Eyssen H J, Mannerts G P. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders. J Inher Metab Dis. 16:1993;381-391.
10. Moon A, Rhead W J. Complementation analysis of fatty acid oxidation disorders. J Clin Invest. 79:1987;59-64.
11. Manning N J, Olpin S E, Pollitt R J, Webley J. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inher Metab Dis. 13:1990;58-68.
12. Freneaux E, Sheffield V C, Molin L, Shires A, Rhead W J. Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations in the alpha subunit of electron transfer flavoprotein in eight patients. J Clin Invest. 90:1992;1679-1686.
13. Olpin S E, Manning N J, Pollitt R J, Clarke S. Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid. J Inher Metab Dis. 18:1997;249-252.
14. Kler R S, Jackson S, Bartlett K, Bindoff L A, Eaton S, Pourfarzam M, Frerman F E, Goodman S I, Watmough N J, Turnbull D M. Quantitation of acyl-coA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem. 266:1991;22932-22938.
15. Pourfarzam M, Schaefer J, Turnbull D M, Bartlett K. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders. Clin Chem. 40:1994;2267-2275.
16. Schaefer J, Pourfarzam M, Bartlett K, Jackson S, Turnbull D M. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation. Pediatr Res. 37:1995;354-360.
17. Nada M A, Rhead W J, Sprecher H, Schulz H, Roe C R. Evidence of intermediate channeling in mitochondrial β-oxidation. J Biol Chem. 270:1995;530-535.
18. Nada M A, Chace D H, Sprecher H, Roe C R. Investigation of β-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry. Biochem Mol Med. 54:1995;59-66.
19. Nada M A, Vianey-Saban C, Roe C R, Ding J-H, Mathieu M, Wappner R S, Bialer M G, McGlynn J A, Mandon G. Prenatal diagnosis of mitochondrial fatty acid oxidation defects. Prenat Diagn. 16:1996;117-124.
20. Yang B-Z, Ding D-H, Roe D S, Dewese T, Day D W, Roe C R. A novel mutation identified in carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 63:1998;110-115.
21. Yang B-Z, Ding D-H, Dewese T, Roe D S, Goucheng H, Wilkinson J, Day D W, Demaugre F, Rabier D, Brivet M, Roe C R. Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency. Mol Genet Metab. 64:1998;229-236.
22. Ventura F V, Costa C G, Struys E A, Ruiter J, Allers P, Ijlst L, Tavares de Almeida I, Duran M, Jakobs C, Wanders R J. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta. 281:1999;1-17.
23. VanHove J LK, Rutledge S L, Nada M A, Kahler S G, Millington D S. 3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl-CoA carboxylase deficiency. J Inher Metab Dis. 18:1995;592-601.
24. Roe C R, Cederbaum S D, Roe D S, Mardach R, Galindo A, Sweetman L. Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism. Mol Genet Metab. 65:1998;264-271.
25. Roe C R, Roe D S. Detection of gene defects in branched chain amino acid catabolism. Abelson JN Simon MI. Methods of Enzymology. 1999;Academic Press, San Diego.
26. Verhoeven N M, Roe D S, Kok R M, Wanders R JA, Jakobs C, Roe C R. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts. J Lipid Res. 39:1998;66-74.
27. Ding D-H, Yang B-Z, Nada M A, Roe C R. Improved detection of the G1528C mutation in LCHAD deficiency. Biochem Mol Med. 58:1996;46-51.
28. Brown-Harrison M C, Nada M A, Sprecher H, Vianey-Saban C, Farquhar J, Gilladoga A G, Roe C R. Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy. Biochem Mol Med. 58:1996;59-65.
29. Vianey-Saban C, Divry P, Brivet M, Nada M A, Zabot M T, Mathieu M, Roe C R. Mitochondrial very-long chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta. 269:1998;43-62.
30. Schmidt-Sommerfield E, Bobrowski P J, Penn D, Rhead W J, Wanders R JA, Bennett M J. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. Pediatr Res. 44:1998;210-214.
31. Allison F, Barnes I CS, Bennett M J. The oxidation of octanoic acid by cultured amniotic fluid cells: the effect of cell type and passage number. Prenat Diagn. 8:1988;383-386.
32. Morris A AM, Olpin S E, Brivet M, Turnbull D M, Jones R AK, Leonard J V. A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr. 132:1998;514.
33. Roe C R, Coates P M. Mitochondrial fatty acid oxidation disorders. The Metabolic and Molecular Bases of Inherited Diseases. 1994;McGraw-Hill, New York. p. 1501-1533.
34. Venizelos N, von Döbeln U, Hagenfeldt L. Fatty acid oxidation in fibroblasts from patients with defects in β-oxidation and in the respiratory chain. J Inher Metab Dis. 21:1998;409-415.
35. Christensen E, Brandt N J, Schmalbrunch H, Kamieniecka Z, Hertz B, Ruitenbeek W. Muscle cytochrome c oxidase deficiency accompanied by a urinary organic acid pattern mimicking multiple acyl-CoA dehydrogenase deficiency. J Inher Metab Dis. 16:1993;553-556.
36. Bennett M J, Weinberger M J, Sherwood W G, Burlina A B. Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis. 17:1994;283-286.
37. Lehnert W, Ruitenbeek W. Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome c oxidase deficiency. J Inher Metab Dis. 16:1993;557-559.
38. Mayatepek K E, Wanders R JA, Hoffmann G E. Mitochondropathy presenting with non-ketotic hypoglycemia as 3-hydroxydicarboxylic aciduria. J Inher Metab Dis. 18:1995;249-252.
39. Frerman F E, Goodman S I. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric aciduria type II. Scriver CR Beaudet AL, Sly WS Valle D. The Metabolic and Molecular Basis of Inherited Metabolic Disease. 1995;1611-1629 McGraw-Hill, New York.
40. Verhoeven N M, Jakobs C, ten Brink H J, Wanders R JA, Roe C R. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis. J Inher Metab Dis. 21:1998;753-760.
41. Verhoeven N M, Schor D SM, Roe C R, Wanders R JA, Jakobs C. Pristanic acid beta oxidation in peroxisomal disorders: studies in cultured human fibroblasts. Biochem Biophys Acta. 1391:1998;351-356.